Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 17855
Country/Region: Uganda
Year: 2017
Main Partner: RTI International
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $1,951,131 Additional Pipeline Funding: $824,697

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $336,758
Care: Orphans and Vulnerable Children (HKID) $299,194
Care: TB/HIV (HVTB) $82,354
Care: Pediatric Care and Support (PDCS) $25,700
Laboratory Infrastructure (HLAB) $32,049
Strategic Information (HVSI) $58,739
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $124,889
Testing: HIV Testing and Counseling (HVCT) $239,343
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $31,732
Treatment: Adult Treatment (HTXS) $698,090
Treatment: Pediatric Treatment (PDTX) $22,283
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 14
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 28
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 97
GEND_GBV Number of people receiving post-GBV care 2018 139
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 76,856
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 50,203
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 101
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 51
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 152
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 76
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 483
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 1,625
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 25
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 25
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 2,196
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 6,589
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 4,393
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 10,981
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 4,393
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 10,981
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 2,196
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 2,196
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 2,415
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 2,818
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 2,415
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 403
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 337
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 48
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 24
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 73
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 36
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 230
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 774
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 12
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 12
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 652
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 326
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 164
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 490
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 245
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 1,550
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 5,222
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 81
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 81
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 385
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 1,460
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 733
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 2,192
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 1,096
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 6,939
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 23,381
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 364
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 364
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 337
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 14
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 7
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 20
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 65
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 217
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 3
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 3
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 5,211
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 6,079
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 5,211
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 868
HTS_TST Sum of Test Result disaggregates 2018 3,489
HTS_TST Sum of Test Result disaggregates 2018 3,740
HTS_TST_POS By Test Result: Positive 2018 3,489
HTS_TST_POS By Test Result: Positive 2018 3,740
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 57
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2018 29
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 86
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 271
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 914
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 116
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 347
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 231
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 578
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 230
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 578
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2018 116
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2018 116
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 123
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 143
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 123
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 41
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 129
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 435
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 218
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 62
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 93
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 46
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 296
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 991
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 87
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 50
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 134
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 156
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 14
OVC_SERV Age/Sex: <1 2018 157
OVC_SERV Age/Sex: 1-9 2018 1,320
OVC_SERV Age/Sex: 10-14 Female 2018 522
OVC_SERV Age/Sex: 10-14 Male 2018 359
OVC_SERV Age/Sex: 15-17 Female 2018 278
OVC_SERV Age/Sex: 15-17 Male 2018 340
OVC_SERV By: Age/sex: 18-24 Female 2018 421
OVC_SERV By: Age/sex: 25+ Female 2018 119
OVC_SERV By: Age/sex: Male 18-24 2018 361
OVC_SERV By: Age/sex: Male 25+ 2018 83
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 3,960
OVC_SERV Program Completion: Active 2018 2,990
OVC_SERV Program Completion: Exited without graduation 2018 198
OVC_SERV Program Completion: Graduation 2018 574
OVC_SERV Program Completion: Transferred 2018 198
OVC_SERV Sum of Age/Sex disaggregates 2018 1,499
PMTCT_ART Already on ART at beginning of current pregnancy 2018 427
PMTCT_ART New on ART 2018 350
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 777
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 8,460
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 654
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 222
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 432
PMTCT_STAT By Age (Numerator): : 15-19 2018 1,607
PMTCT_STAT By Age (Numerator): 10-14 2018 85
PMTCT_STAT By Age (Numerator): 20-24 2018 1,607
PMTCT_STAT By Age (Numerator): 25-49 2018 5,161
PMTCT_STAT By known positives: 10-14 2018 4
PMTCT_STAT By known positives: 15-19 2018 78
PMTCT_STAT By known positives: 20-24 2018 139
PMTCT_STAT By known positives: 25-49 2018 188
PMTCT_STAT By new negatives: 10-14 2018 77
PMTCT_STAT By new negatives: 15-19 2018 1,451
PMTCT_STAT By new negatives: 20-24 2018 1,329
PMTCT_STAT By new negatives: 25-49 2018 4,785
PMTCT_STAT By new positives: 10-14 2018 4
PMTCT_STAT By new positives: 15-19 2018 78
PMTCT_STAT By new positives: 20-24 2018 139
PMTCT_STAT By new positives: 25-49 2018 188
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 8,460
PMTCT_STAT_den By Age (Denominator): 10-14 2018 85
PMTCT_STAT_den By Age (Denominator): 15-19 2018 1,607
PMTCT_STAT_den By Age (Denominator): 20-24 2018 1,607
PMTCT_STAT_den By Age (Denominator): 25-49 2018 5,161
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 16
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 173
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 21
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 313
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 551
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 523
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 17
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 182
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 22
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 330
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 908
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 2,121
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 3,029
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 3,029
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 6,059
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 1,817
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 4,242
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 6,059
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 31
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 345
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 42
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 628
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,046
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,046
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 31
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 345
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 42
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 628
TX_CURR Age/Sex: <1 2018 118
TX_CURR Age/Sex: 1-9 2018 118
TX_CURR Age/Sex: 10-14 Female 2018 236
TX_CURR Age/Sex: 10-14 Male 2018 236
TX_CURR Age/Sex: 15-19 Female 2018 1,244
TX_CURR Age/Sex: 15-19 Male 2018 389
TX_CURR Age/Sex: 20-24 Female 2018 1,867
TX_CURR Age/Sex: 20-24 Male 2018 531
TX_CURR Age/Sex: 25-49 Female 2018 5,911
TX_CURR Age/Sex: 25-49 Male 2018 12,453
TX_CURR Age/Sex: 50+ Female 2018 311
TX_CURR Age/Sex: 50+ Male 2018 195
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 23,609
TX_CURR Sum of Age/Sex disaggregations 2018 1,633
TX_NEW Breastfeeding status 2018 21
TX_NEW By Age/Sex: 15-19 Female 2018 269
TX_NEW By Age/Sex: 15-19 Male 2018 135
TX_NEW By Age/Sex: 20-24 Female 2018 404
TX_NEW By Age/Sex: 20-24 Male 2018 202
TX_NEW By Age/Sex: 25-49 Female 2018 1,279
TX_NEW By Age/Sex: 25-49 Male 2018 4,309
TX_NEW By Age/Sex: 50+ Female 2018 67
TX_NEW By Age/Sex: 50+ Male 2018 67
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 6,732
TX_NEW Pregnancy status 2018 1,683
TX_NEW Sum of Age/Sex disaggregates 2018 6,732
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 21,248
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 19,123
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 287
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 287
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 7,559
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 10,990
TX_PVLS Numerator: Indication: Routine 2018 19,123
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 95
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 1,913
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 319
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 319
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,399
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 12,211
TX_PVLS_den Denominator: Indication: Routine 2018 21,248
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 106
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 2,125
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 66
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 58
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,046
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 620
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,790
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,977
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 67
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 59
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,162
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 689
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 23,609
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 472
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 7
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 7
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 187
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 271
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 354
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 354
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 9,333
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 13,568
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,322
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 189
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 378
TX_TB_den Denominator: By Screen Result: Negative 2018 21,720
TX_TB_den Denominator: By Screen Result: Positive 2018 1,889
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 1,889
VMMC_CIRC By Age: 15-19 2018 3,190
VMMC_CIRC By Age: 20-24 2018 4,254
VMMC_CIRC By Age: 25-29 2018 8,507
VMMC_CIRC By Age: 30-49 2018 1,063
VMMC_CIRC By Age: 50+ 2018 709
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 17,723
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 17,723
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 8,153
Cross Cutting Budget Categories and Known Amounts Total: $87,000
Gender: Gender Based Violence (GBV) $10,000
GBV Prevention
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Capacity building
Implementation
Monitoring and Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery $5,000
Economic Strengthening $10,000
Motor Vehicles: Purchased $52,000
Condoms: Policy, Tools, and Services $10,000